Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 5, 2011, Pages 473.e1-473.e9

  Moro, Pedro L ^a   Broder, Karen ^a   Zheteyeva, Yenlik ^b   Revzina, Natalya ^c   Tepper, Naomi ^c   Kissin, Dmitry ^c   Barash, Faith ^d   Arana, Jorge ^a   Brantley, Mary D ^c   Ding, Helen ^b   Singleton, James A ^b   Walton, Kimp ^a   Haber, Penina ^a   Lewis, Paige ^a   Yue, Xin ^a   Destefano, Frank ^a   Vellozzi, Claudia ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

influenza A (H1N1); pregnancy; surveillance; vaccine safety

Indexed keywords

INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; CLEFT LIP; FEMALE; FETAL HYDRONEPHROSIS; FETAL TACHYCARDIA; HUMAN; HYDRONEPHROSIS; IMMINENT ABORTION; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POSTMARKETING SURVEILLANCE; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH; TACHYCARDIA;

EID: 80255140411     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.06.047     Document Type: Article

References (43)

1. A.E. Fiore, D.K. Shay, and K. Broder Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009 MMWR Morb Mortal Wkly Rep Recomm Rep 58 2009 1 52
2. D.M. Skowronski, and G. De Serres Is routine influenza immunization warranted in early pregnancy? Vaccine 27 2009 4754 4770
3. Centers for Disease Control and Prevention Swine influenza A (H1N1) infection in two childrensouthern California, March-April 2009 MMWR Morb Mortal Wkly Rep 58 2009 400 402
4. D.J. Jamieson, M.A. Honein, and S.A. Rasmussen H1N1 2009 influenza virus infection during pregnancy in the USA Lancet 374 2009 451 458
5. Centers for Disease Control and Prevention Use of Influenza A (H1N1) 2009 Monovalent Vaccine Recommendations of the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep 58 2009 1 8
6. Food and Drug Administration Influenza A (H1N1) 2009 monovalent http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181950. htm Accessed Jan. 4, 2010
7. Food and Drug Administration Vaccines licensed for immunization and distribution in the US with supporting documents (influenza vaccine) http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093830. htm Accessed Jan. 4, 2010
8. P.D. Tamma, K.A. Ault, C. Del Rio, M.C. Steinhoff, N.A. Halsey, and S.B. Omer Safety of influenza vaccination during pregnancy Am J Obstet Gynecol 201 2009 547 552
9. C. Vellozzi, D.R. Burwen, A. Dobardzic, R. Ball, K. Walton, and P. Haber Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring Vaccine 27 2009 2114 2120
10. M. Rosenberg, R. Sparks, A. McMahon, J. Iskander, J.D. Campbell, and K.M. Edwards Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age Vaccine 27 2009 4278 4283
11. F. Varricchio, J. Iskander, and F. Destefano Understanding vaccine safety information from the Vaccine Adverse Event Reporting System Pediatr Infect Dis J 23 2004 287 294 (Pubitemid 38508877)
12. Food and Drug Administration 21 CFR Part 600.80 Postmarketing reporting of adverse experiences Fed Regist 62 1997 52252 52253
13. Medical dictionary for regulatory activities http://www.meddramsso.com/ MSSOWeb/index.htm Accessed Aug. 24, 2009
14. G. Cunningham, K.J. Leveno, S.L. Bloom, J.C. Hauth, L.C. Gilstrap, and K.D. Wenstrom Williams obstetrics 2001 McGraw-Hill Companies, Inc New York
15. K.S. Kohl, J. Gidudu, and J. Bonhoeffer The development of standardized case definitions and guidelines for adverse events following immunization Vaccine 25 2007 5671 5674 (Pubitemid 47043207)
16. J.J. Sejvar, K.S. Kohl, and J. Gidudu Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data Vaccine 29 2011 599 612
17. J.U. Ruggeberg, M.S. Gold, and J.M. Bayas Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data Vaccine 25 2007 5675 5684 (Pubitemid 47049764)
18. Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverageUnited States, October 2009 through January 2010 MMWR Morbid Mortal Wkly Rep 59 2010 363 368 http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5912a2.htm Accessed July 27, 2010
19. B.E. Hamilton, J.A. Martin, and S.J. Ventura Births: preliminary data for 2008 National vital statistics reports, vol 58, no 16 April 6, 2010 National Center for Health Statistics Hyattsville, MD http://www.cdc.gov/nchs/data/nvsr/ nvsr58/nvsr58-16.pdf Accessed May 4, 2010
20. Centers for Disease Control and Prevention Abortion surveillanceUnited States, 2006 Surveillance summaries, Nov. 27, 2009 MMWR Morbid Mortal Wkly Rep 58 no. SS-8 2009 http://www.cdc.gov/mmwr/pdf/ss/ss5808.pdf Accessed May 4, 2010
21. S. Ventura, J.C. Abma, and W.D. Mosher Estimated pregnancy rates for the United States, 1990-2005: an update. National Vital Statistics Reports, vol 58, no 4 (Oct. 14, 2009) http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58-04.pdf Accessed May 4, 2010
22. US Census Bureau, Population Estimates Program http://factfinder.census. gov/servlet/DatasetMainPageServlet?-program=PEP&-submenuId= datasets-3&-lang=en Accessed May 4, 2010
23. N.R. Hartnell, and J.P. Wilson Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration Pharmacotherapy 24 2004 743 749 (Pubitemid 38747859)
24. H.S. Izurieta, P. Haber, and R.P. Wise Adverse events reported following live, cold-adapted, intranasal influenza vaccine JAMA 294 2005 2720 2725 (Pubitemid 41770101)
25. S.S. Chaves, P. Haber, and K. Walton Safety of varicella vaccine after licensure in the United States: experience from reports to the Vaccine Adverse Event Reporting System, 1995-2005 J Infect Dis 197 Suppl 2 2008 S170 S177
26. S.J. Ventura, J.C. Abma, and W.D. Mosher Estimated pregnancy rates by outcome for the United States, 1990-2004 Natl Vital Stat Rep 56 2008 1 28 http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56-15.pdf Accessed Aug. 24, 2009
27. S. Black, J. Eskola, and C.A. Siegrist Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines Lancet 374 2009 2115 2122
28. A.B. Wallis, A.F. Saftlas, J. Hsia, and H.K. Atrash Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004 Am J Hypertens 21 2008 521 526 (Pubitemid 351589674)
29. E.J. Woo, R. Ball, and A. Bostrom Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001 Am J Public Health 94 2004 990 995 (Pubitemid 38691545)
30. M.F. MacDorman, and S. Kirmeyer Fetal and perinatal mortality, United States, 2005 Natl Vital Stat Rep 57 2009 1 20 http://www.cdc.gov/nchs/data/nvsr/ nvsr57/nvsr57-08.pdf Accessed May 6, 2010
31. P.L. Moro, K. Broder, and Y. Zheteyeva Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009 A J Obstet Gynecol 204 2011 146.e1 146.e7
32. C. Vellozzi, K.R. Broder, and P. Haber Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009 through January 31, 2010 Vaccine 28 2010 7248 7255
33. Centers for Disease Control and Prevention (CDC) Safety of influenza A (H1N1) 2009 monovalent vaccinesUnited States, October 1 through November 24, 2009 MMWR Morb Mortal Wkly Rep 58 2009 1351 1356 http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm58e1204a1.htm Accessed Feb. 2, 2010
34. J.L. Shapiro, M.H. Yudin, and J.G. Ray Bell's palsy and tinnitus during pregnancy: predictors of preeclampsia: three cases and a detailed review of the literature Acta Otolaryngol 119 1999 647 651 (Pubitemid 29513774)
35. S. Rowlands, R. Hooper, R. Hughes, and P. Burney The epidemiology and treatment of Bell's palsy in the UK Eur J Neurol 9 2002 63 67
36. O.P. Heinonen, S. Shapiro, R.R. Monson, S.C. Hartz, L. Rosenber, and D. Slone Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy Int J Epidemiol 2 1973 229 235
37. F.M. Munoz, A.J. Greisinger, and O.A. Wehmanen Safety of influenza vaccination during pregnancy Am J Obstet Gynecol 192 2005 1098 1106 (Pubitemid 40487785)
38. Centers for Disease Control and Prevention (CDC) Intussusception among recipients of rotavirus vaccineUnited States, 1998-1999 MMWR Morb Mortal Wkly Rep 48 1999 577 581
39. P. Kramarz, E.K. France, and F. Destefano Population-based study of rotavirus vaccination and intussusception Pediatr Infect Dis J 20 2001 410 416 (Pubitemid 32294750)
40. T.V. Murphy, P.M. Gargiullo, and M.S. Massoudi Intussusception among infants given an oral rotavirus vaccine N Engl J Med 344 2001 564 572 (Pubitemid 32167870)
41. P. Haber, R.T. Chen, L.R. Zanardi, G.T. Mootrey, R. English, M.M. Braun VAERS Working Group An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone? Pediatrics 113 2004 e353 e359
42. Federal Immunization Safety Task Force Federal plans to monitor immunization safety for the pandemic 2009 H1N1 Influenza Vaccination Program http://www.flu.gov/professional/federal/monitor-immunization-safety.html Accessed June 4, 2010
43. The Vaccines and Medications in Pregnancy Surveillance System (VAMPSS) http://www.otispregnancy.org/vaccines-and-medications-in-pregnancy-surveillance- system-vampss-s13053 Accessed June 4, 2010